Cloetta Ab (publ) Earnings Calls
| Release date | Jul 15, 2026 |
| EPS estimate | $0.0724 |
| EPS actual | $0.0796 |
| EPS Surprise | 9.99% |
| Revenue estimate | 214.335M |
| Revenue actual | 215.827M |
| Revenue Surprise | 0.696% |
| Release date | May 06, 2026 |
| EPS estimate | $0.0694 |
| EPS actual | $0.0768 |
| EPS Surprise | 10.62% |
| Revenue estimate | 222.814M |
| Revenue actual | 222.182M |
| Revenue Surprise | -0.283% |
| Release date | Feb 04, 2026 |
| EPS estimate | $0.0676 |
| EPS actual | $0.0866 |
| EPS Surprise | 27.99% |
| Revenue estimate | 244.099M |
| Revenue actual | 241.394M |
| Revenue Surprise | -1.11% |
| Release date | Nov 05, 2025 |
| EPS estimate | $0.0572 |
| EPS actual | $0.0702 |
| EPS Surprise | 22.68% |
| Revenue estimate | 244.474M |
| Revenue actual | 230.556M |
| Revenue Surprise | -5.69% |
Last 4 Quarters for Cloetta Ab (publ)
Below you can see how CLOEF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 05, 2025 |
| Price on release | $3.54 |
| EPS estimate | $0.0572 |
| EPS actual | $0.0702 |
| EPS surprise | 22.68% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $3.54 |
| Oct 31, 2025 | $3.71 |
| Nov 03, 2025 | $3.54 |
| Nov 04, 2025 | $3.54 |
| Nov 05, 2025 | $3.54 |
| Nov 06, 2025 | $3.54 |
| Nov 07, 2025 | $3.71 |
| Nov 10, 2025 | $3.54 |
| Nov 11, 2025 | $3.54 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Feb 04, 2026 |
| Price on release | $4.45 |
| EPS estimate | $0.0676 |
| EPS actual | $0.0866 |
| EPS surprise | 27.99% |
| Date | Price |
|---|---|
| Jan 29, 2026 | $4.45 |
| Jan 30, 2026 | $4.45 |
| Feb 02, 2026 | $4.45 |
| Feb 03, 2026 | $4.45 |
| Feb 04, 2026 | $4.45 |
| Feb 05, 2026 | $4.45 |
| Feb 06, 2026 | $4.45 |
| Feb 09, 2026 | $4.45 |
| Feb 10, 2026 | $4.45 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | May 06, 2026 |
| Price on release | $5.38 |
| EPS estimate | $0.0694 |
| EPS actual | $0.0768 |
| EPS surprise | 10.62% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $5.80 |
| May 01, 2026 | $5.80 |
| May 04, 2026 | $5.80 |
| May 05, 2026 | $5.80 |
| May 06, 2026 | $5.38 |
| May 07, 2026 | $5.38 |
| May 08, 2026 | $5.38 |
| May 11, 2026 | $5.38 |
| May 12, 2026 | $5.38 |
| 4 days before | -7.27% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -7.27% |
| Release date | Jul 15, 2026 |
| Price on release | $5.60 |
| EPS estimate | $0.0724 |
| EPS actual | $0.0796 |
| EPS surprise | 9.99% |
| Date | Price |
|---|---|
| Jul 09, 2026 | $5.60 |
| Jul 10, 2026 | $5.60 |
| Jul 13, 2026 | $5.60 |
| Jul 14, 2026 | $5.60 |
| Jul 15, 2026 | $5.60 |
| Jul 16, 2026 | $5.60 |
| Jul 17, 2026 | $5.60 |
| Jul 20, 2026 | $5.60 |
| Jul 21, 2026 | $5.60 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Cloetta Ab (publ) Earnings Call Transcript Summary of Q2 2026
Cloetta reported a very strong Q2 2026 with exceptional profitability and continued volume-driven organic growth. Key financials: H1 organic growth 3.8% (within the 3–4% long-term target), Q2 adjusted EBIT margin 14.9% and YTD adjusted EBIT margin 13.9%, net debt/EBITDA 0.8x (well below the <1.5x target), improved free cash flow (SEK 230m YTD) and a record dividend paid in Q2. Strategy and operational priorities: focus on 10 Superbrands in five core markets (Sweden, Denmark, Norway, Finland, Netherlands), expansion in three beyond-core markets (UK, Germany, North America), step-up in CapEx to ~4–5% of NSV midterm directed to capacity, automation, supply-chain resilience and digitalization (AI-enabled planning). Management reiterated a disciplined make-or-buy approach for production, prioritized diversified investments across technologies (not redoing the canceled single greenfield approach), and emphasized culture, Net Revenue Management and process excellence driving mix and operational efficiency. Near-term outlook/market deployment: selected SKU national rollout in the U.S. underway (packaged SKUs), Pick & Mix pilots expanding (five stores in Germany, first CandyKing Pick & Mix concept launched in a U.S. retailer), but H2 will include higher one-off/startup costs (marketing, organizational costs for geographic expansion) which management said will reduce Q3–Q4 margins versus Q2 and therefore investors should not expect the Q2 margin level to persist for the full second half. Overall position: strong balance sheet and liquidity to support growth and opportunistic M&A (not required for target achievement); management expects to be on track to reach the 12% midterm adjusted EBIT target by 2027 (and said it is within sight for full-year 2026).
Sign In
Buy CLOEF